---
title: CONTINUUS Pharmaceuticals vs Flamma
slug_a: continuuspharma
slug_b: flammagroup
site: cdmo
review_signal_gate: closed
canonical_path: /compare/continuuspharma/flammagroup
generated_by: BioBM Editorial AI
---

# CONTINUUS Pharmaceuticals vs Flamma

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

CONTINUUS Pharmaceuticals (continuuspharma) is listed for cdmo. CONTINUUS Pharmaceuticals specializes in Integrated Continuous Manufacturing (ICM)—a transformative approach that replaces traditional batch processes with end-to-end continuous flows for active pharmaceutical ingredients (APIs) and final dosage forms.

Services: 6. Modalities: 1. Indications: 0. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (6).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Flamma (flammagroup) is listed for cdmo. Privately held small molecule CDMO with FDA-inspected cGMP facilities in Italy, USA, and China, offering custom manufacturing, development, and specialized technologies including HPAPI, continuous flow, and cryogenic API synthesis from early-stage to commercial scale.

Services: 9. Modalities: 1. Indications: 0. Locations: 7. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (9).

Review summary: Review summary withheld until site-level review gate opens.